GlassScriptPhysician profile
Brandon B Khaw
NPI 1568453637
$3,850.96
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $247 · 2022: $959 · 2023: $1,287 · 2024: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,669.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $930.06 | 2019-2024 | Farxiga, Airsupra |
| Pfizer INC. | $485.52 | 2019-2020 | |
| Novo Nordisk INC | $465.08 | 2022-2024 | Wegovy |
| Amgen INC. | $365.43 | 2022-2023 | Repatha, Otezla |
| Lilly USA, LLC | $355.26 | 2022-2024 | Mounjaro |
| Glaxosmithkline, LLC. | $350.10 | 2019-2023 | Arexvy |
| Abbvie INC. | $277.40 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $228.40 | 2019-2022 | |
| Sanofi Pasteur INC. | $127.24 | 2019 | |
| Allergan, INC. | $124.29 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.17 | 2023 | Jardiance |
| Abbott Laboratories | $23.97 | 2019 | |
| Medtronic USA, INC. | $20.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Khaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.